INCREASING BIOMASS ACCUMULATION AND WITHAFERIN A PRODUCTION IN CELL SUSPENSION CULTURE OF WITHANIA SOMNIFERA

Authors

  • SIMMI JAIN, MANISH K JAIN SMITA BANERJEE Department of Biotechnology, School of Biological Sciences, Dr H. S. Gour University, Sagar, MP, INDIA

Keywords:

Withaferin-A, suspension culture, bioreactors.

Abstract

Withania somnifera, commonly known as Ashwagandha, is a valued herb in Ayurvedic medicine. Roots, leaves and preparations of the plant are traditionally used as tonic, hypnotic, sedative and diuretic. W. somnifera mainly contains withanolides which are biologically active secondary metabolites present in roots and leaves. In the present study, we have standardized the protocol for the extraction and purification of Withaferin A from the cell suspension cultures of W. somnifera. Withanferin A is having a high medicinal value and possesses potent anti-tumor and antioxidant properties. In the present study the callus was obtained from leaves as explant. Highly profuse and friable callus was then used as inoculum for suspension culture. Here different combinations of phytohormones viz. IAA+BAP (1.0+0.8mg/l) and NAA+ BAP (0.5+1mg/l) were used. This study involves a detailed investigation about the accumulation of secondary metabolite content, in in vivo cell suspension, both quantitatively and qualitatively. Pure compounds were extracted and identified using the simple techniques viz., Thin Layer Chromatograpy and High Pressure Liquid Chromatography. The growth of biomass in suspension culture of W. somnifera was calculated in interval of subsequent culture days in terms of fresh biomass of callus. After crossing lag phase, the cells in suspension culture entered log phase and maximum increase in biomass was observed between 15-20 days. Thus the maximum callus biomass 0.41g/80ml was observed in suspension culture from NAA+BAP (0.5+1.0mg) and TLC study is also clear and distinct. HPLC analysis confirms the presence of withaferin-A in the suspension culture of W. somnifera. This is a step towards using cell suspension in disposable bioreactors

References

Gupta GL and Rana AC, Withania somnifera (Ashwagandha): A Review. Pharmacog Rev, 1: 129-136 (2007). Atta UR, Jamal SA, Choudhary MI and Asif E, Two withanolides from Withania somnifera. Phytochem 30:3824–3826, (1991). Devi PU, Kamath R and Rao BSS, Radio sensitization of a mouse melanoma by withaferin A: in vitro studies. Ind J Exp Biol 38:432–437, (2000).

Global Journal of Multidisciplinary Studies Available online at www.journal.edwin.co.in

Volume 3, Issue 12, November 2014

ISSN: - 2348-0459

An international double – blind peer reviewed, refereed and Indexed Journal with Impact Factor 1.927

Zhao J, Nakamura N, Hattori M, Kuboyama T, Tohda C and Komatsu K, Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem Pharm Bull 50:760–765, (2002). Jayaprakasam B, Zhang YJ, Seeram NP and Nair MG, Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci, 74: 125–134 (2003). Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair, MG and Aggarwal BB, Withanolides potentiate apoptosis, inhibit invasion and abolish osteoclastogenesis through suppression of nuclear factor-kappa B (NF-kappa B) activation and NF-kappa B regulated gene expression. Mol Cancer Ther, 5: 1434– 1445 (2006). Ciddi V (2010). Withaferin A from cell cultures of Withania somnifera. Indian J. Pharm. Sci. 68:490. Bhandari MM (1995). Flora of the Indian desert. MPS Repros Jodhpur, India. Hepper FN (1991). Old World Withania (Solanaceae): a taxonomic review and key to the species. In: Hawkes JG, Lester RN, Estrada N 5398 J. Med. Plants Res. (eds), Solanaceae III: Taxonomy, Chemistry, Evolution. RBG Kew, Richmond, Surrey. pp.211-227.

Negi MS, Sabharwal V, Wilson N, Lakshmikumaran MS (2006). Comparative analysis of the efficiency of SAMPL and AFLP in assessing genetic relationships among Withaniasomnifera genotypes. Curr Sci. 91:464-471.

Downloads

Published

2014-11-30